Electron transport chain capacity expands yellow fever vaccine immunogenicity.

Autor: Mok DZ; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Tng DJ; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore., Yee JX; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore., Chew VS; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore., Tham CY; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore., Ooi JS; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Tan HC; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Zhang SL; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Lin LZ; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Ng WC; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Jeeva LL; SingHealth Investigational Medicine Unit, Singapore General Hospital, Singapore, Singapore., Murugayee R; SingHealth Investigational Medicine Unit, Singapore General Hospital, Singapore, Singapore., Goh KK; Department of Pharmacy, Singapore General Hospital, Singapore, Singapore., Lim TP; Department of Pharmacy, Singapore General Hospital, Singapore, Singapore., Cui L; Singapore-MIT Alliance for Research and Technology, Antimicrobial Resistance Interdisciplinary Research Group, Campus for Research Excellence and Technological Enterprise, Singapore, Singapore., Cheung YB; Center for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore.; Center for Child, Adolescent and Maternal Health Research, Tampere University, Tampere, Finland., Ong EZ; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore., Chan KR; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Ooi EE; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore. engeong.ooi@duke-nus.edu.sg.; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore. engeong.ooi@duke-nus.edu.sg.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore. engeong.ooi@duke-nus.edu.sg.; Department of Translational Clinical Research, Singapore General Hospital, Singapore, Singapore. engeong.ooi@duke-nus.edu.sg., Low JG; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore. jenny.low@singhealth.com.sg.; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore. jenny.low@singhealth.com.sg.; Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore. jenny.low@singhealth.com.sg.

Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2024 Jun; Vol. 16 (6), pp. 1310-1323. Date of Electronic Publication: 2024 May 14.